Mechanisms of Hybrid Oligomer Formation in the Pathogenesis of Combined Alzheimer's and Parkinson's Diseases

A smooth particle mesh Ewald method

Essmann, U., Perera, L., Berkowitz, M., Darden, T., Lee, H.-C., & Pedersen, L. (1995) · The Journal of Chemical Physics · doi:10.1063/1.470117 · Cited by 21,329 · see citing works

α-Synuclein in Lewy bodies

Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382 · see citing works

Lipid rafts and signal transduction

Simons, K., & Toomre, D. K. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35036052 · Cited by 6,252 · see citing works

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide

Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744 · see citing works

Constant pressure molecular dynamics simulation: The Langevin piston method

Feller, S., Zhang, Y., Pastor, R., & Brooks, B. (1995) · The Journal of Chemical Physics · doi:10.1063/1.470648 · Cited by 4,267 · see citing works

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop

McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960 · see citing works

Reversible multiple time scale molecular dynamics

Tuckerman, M. E., Berne, B. J., & Martyna, G. J. (1992) · The Journal of Chemical Physics · doi:10.1063/1.463137 · Cited by 3,566 · see citing works

NAMD2: Greater Scalability for Parallel Molecular Dynamics

Kalé, L. V., Skeel, R. D., Bhandarkar, M. A., Brunner, R., Gürsoy, A., Krawetz, N., Phillips, J., Shinozaki, A., Varadarajan, K., & Schulten, K. J. (1999) · Journal of Computational Physics · doi:10.1006/jcph.1999.6201 · Cited by 2,428 · see citing works

Dopaminergic Loss and Inclusion Body Formation in α-Synuclein Mice: Implications for Neurodegenerative Disorders

Masliah, E., Rockenstein, E. M., Veinbergs, I., Mallory, M. E., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A., & Mucke, L. (2000) · Science · doi:10.1126/science.287.5456.1265 · Cited by 1,763 · see citing works

P <scp>ROTOFIBRILS</scp> , P <scp>ORES</scp> , F <scp>IBRILS, AND</scp> N <scp>EURODEGENERATION</scp> : Separating the Responsible Protein Aggregates from The Innocent Bystanders

Caughey, B., & Lansbury, P. T. (2003) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.010302.081142 · Cited by 1,650 · see citing works

Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP

Lewis, J., Dickson, D. W., Lin, W.-L., Chisholm, L., Corral, A., Jones, G., Yen, S.-H., Sahara, N., Skipper, L., Yager, D., et al. (2001) · Science · doi:10.1126/science.1058189 · Cited by 1,611 · see citing works

Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapy

Conway, K. A., Lee, S., Rochet, J., Ding, T. T., Williamson, R. E., & Lansbury, P. T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.571 · Cited by 1,543 · see citing works

Lipid Rafts

Munro, S. (2003) · Cell · doi:10.1016/s0092-8674(03)00882-1 · Cited by 1,508 · see citing works

The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system

Iwai, A., Masliah, E., Yoshimoto, M., Ge, N., Flanagan, L., Rohan de Silva, H. A., Kittel, A., & Saitoh, T. (1995) · Neuron · doi:10.1016/0896-6273(95)90302-x · Cited by 1,316 · see citing works

Conformational properties of α-synuclein in its free and lipid-associated states 1 1Edited by P. E. Wright

Eliezer, D., Kutluay, E., Bussell, R., & Browne, G. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4538 · Cited by 1,077 · see citing works

Targeting small Aβ oligomers: the solution to an Alzheimer's disease conundrum?

Klein, W. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01749-5 · Cited by 989 · see citing works

Amyloid ion channels: A common structural link for protein-misfolding disease

Quist, A. P., Doudevski, I., Lin, H., Azimova, R., Ng, D., Frangione, B., Kagan, B. L., Ghiso, J. A., & Lal, R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502066102 · Cited by 982 · see citing works

Structure and Dynamics of Micelle-bound Human α-Synuclein

Ulmer, T. S., Bax, A., Cole, N. B., & Nussbaum, R. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411805200 · Cited by 966 · see citing works

Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum.

Arispe, N. J., Rojas, E., & Pollard, H. B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.567 · Cited by 921 · see citing works

Initiation and Synergistic Fibrillization of Tau and Alpha-Synuclein

Giasson, B. I., Forman, M. S., Higuchi, M., Golbe, L. I., Graves, C. L., Kotzbauer, P. T., Trojanowski, J. Q., & Lee, V. M.-Y. (2003) · Science · doi:10.1126/science.1082324 · Cited by 879 · cited 1× · see citing works

Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide

Haass, C., & Selkoe, D. J. (1993) · Cell · doi:10.1016/0092-8674(93)90312-e · Cited by 833 · see citing works

α-Synuclein, Especially the Parkinson's Disease-associated Mutants, Forms Pore-like Annular and Tubular Protofibrils

Lashuel, H. A., Petre, B. M., Wall, J. S., Simon, M. N., Nowak, R. J., Walz, T., & Lansbury, P. T. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00735-0 · Cited by 802 · see citing works

Different Species of α-Synuclein Oligomers Induce Calcium Influx and Seeding

Danzer, K. M., Haasen, D., Karow, A. R., Moussaud, S., Habeck, M., Giese, A., Kretzschmar, H. A., Hengerer, B., & Kostka, M. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.2617-07.2007 · Cited by 798 · see citing works

Intravesicular Localization and Exocytosis of α-Synuclein and its Aggregates

Lee, H.-J., Patel, S. S., & Lee, S. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.0692-05.2005 · Cited by 798 · see citing works

An Improved Empirical Potential Energy Function for Molecular Simulations of Phospholipids

Feller, S. E., & MacKerell, A. D. (2000) · The Journal of Physical Chemistry B · doi:10.1021/jp0007843 · Cited by 766 · see citing works

Synucleins Are Developmentally Expressed, and α-Synuclein Regulates the Size of the Presynaptic Vesicular Pool in Primary Hippocampal Neurons

Murphy, D. D., Rueter, S. M., Trojanowski, J. Q., & Lee, V. M. ‐. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-09-03214.2000 · Cited by 753 · see citing works

Calcium and neurodegeneration

Mattson, M. P. (2007) · Aging Cell · doi:10.1111/j.1474-9726.2007.00275.x · Cited by 751 · see citing works

Simultaneous Binding of PtdIns(4,5)P 2 and Clathrin by AP180 in the Nucleation of Clathrin Lattices on Membranes

Ford, M. G. J., Pearse, B. M. F., Higgins, M. K., Vallis, Y., Owen, D. J., Gibson, A., Hopkins, C. R., Evans, P. R., & McMahon, H. T. (2001) · Science · doi:10.1126/science.291.5506.1051 · Cited by 727 · see citing works

Distinct sites of intracellular production for Alzheimer's disease Aβ40/42 amyloid peptides

Hartmann, T., Bieger, S. C., Brühl, B., Tienari, P. J., Ida, N., Allsop, D., Roberts, G. W., Masters, C. L., Dotti, C. G., Unsicker, K., et al. (1997) · Nature Medicine · doi:10.1038/nm0997-1016 · Cited by 706 · see citing works

Generalized Verlet Algorithm for Efficient Molecular Dynamics Simulations with Long-range Interactions

Grubmüller, H., Heller, H., Windemuth, A., & Schulten, K. J. (1991) · Molecular Simulation · doi:10.1080/08927029108022142 · Cited by 703 · see citing works

Vesicle Permeabilization by Protofibrillar α-Synuclein: Implications for the Pathogenesis and Treatment of Parkinson's Disease

Volles, M. J., Lee, S., Rochet, J., Shtilerman, M. D., Ding, T. T., Kessler, J. C., & Lansbury, P. T. (2001) · Biochemistry · doi:10.1021/bi0102398 · Cited by 682 · see citing works

Amyloid β protein forms ion channels: implications for Alzheimer's disease pathophysiology

LIN, H., Bhatia, R., & Lal, R. (2001) · The FASEB Journal · doi:10.1096/fj.01-0377com · Cited by 641 · see citing works

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the Consortium on DLB International Workshop

McKeith, I. G. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9s347 · Cited by 625 · see citing works

β-Amyloid peptides enhance α-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease

Masliah, E., Rockenstein, E., Veinbergs, I., Sagara, Y., Mallory, M., Hashimoto, M., & Mucke, L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211412398 · Cited by 607 · see citing works

Emerging Themes in Lipid Rafts and Caveolae

Galbiati, F., Razani, B., & Lisanti, M. P. (2001) · Cell · doi:10.1016/s0092-8674(01)00472-x · Cited by 567 · see citing works

DLB and PDD boundary issues: Diagnosis, treatment, molecular pathology, and biomarkers

Lippa, C. F., Duda, J. E., Grossman, M., Hurtig, H. I., Aarsland, D., Boeve, B. F., Brooks, D. J., Dickson, D. W., Dubois, B., Emre, M., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000256715.13907.d3 · Cited by 548 · see citing works

Lewy Bodies Contain Altered α-Synuclein in Brains of Many Familial Alzheimer's Disease Patients with Mutations in Presenilin and Amyloid Precursor Protein Genes

Lippa, C. F., Fujiwara, H., Mann, D. M. A., Giasson, B., Baba, M., Schmidt, M. L., Nee, L. E., O'Connell, B., Pollen, D. A., St. George-Hyslop, P., et al. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65722-7 · Cited by 533 · see citing works

Lipid Rafts Mediate the Synaptic Localization of α-Synuclein

Fortin, D. L., Troyer, M. D., Nakamura, K., Kubo, S., Anthony, M. D., & Edwards, R. H. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1594-04.2004 · Cited by 518 · see citing works

The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice

LaFerla, F. M., Tinkle, B. T., Bieberich, C. J., Haudenschild, C. C., & Jay, G. (1995) · Nature Genetics · doi:10.1038/ng0195-21 · Cited by 513 · see citing works

Amyloid-β oligomers: their production, toxicity and therapeutic inhibition

Walsh, D. M., Klyubin, I. V., Fadeeva, J. V., Rowan, M. J., & Selkoe, D. J. (2002) · Biochemical Society Transactions · doi:10.1042/bst0300552 · Cited by 507 · see citing works

The Aggregation and Fibrillation of α-Synuclein

Fink, A. L. (2006) · Accounts of Chemical Research · doi:10.1021/ar050073t · Cited by 503 · see citing works

Role of Protein Aggregation in Mitochondrial Dysfunction and Neurodegeneration in Alzheimer's and Parkinson's Diseases

Hashimoto, M., Rockenstein, E. M., Crews, L. A., & Masliah, E. (2003) · NeuroMolecular Medicine · doi:10.1385/nmm:4:1-2:21 · Cited by 498 · see citing works

Vesicle Permeabilization by Protofibrillar α-Synuclein Is Sensitive to Parkinson's Disease-Linked Mutations and Occurs by a Pore-like Mechanism

Volles, M. J., & Lansbury, P. T. (2002) · Biochemistry · doi:10.1021/bi0121353 · Cited by 485 · see citing works

Annual Incidence of Alzheimer Disease in the United States Projected to the Years 2000 Through 2050

Hebert, L. E., Beckett, L. A., Scherr, P. A., & Evans, D. A. (2001) · Alzheimer Disease and Associated Disorders · doi:10.1097/00002093-200110000-00002 · Cited by 467 · see citing works

Lipid Droplet Binding and Oligomerization Properties of the Parkinson's Disease Protein α-Synuclein

Cole, N. B., Murphy, D. D., Grider, T., Rueter, S. M., Brasaemle, D., & Nussbaum, R. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108414200 · Cited by 466 · see citing works

Oligomers on the Brain: the Emerging Role of Soluble Protein Aggregates in Neurodegeneration.

Walsh, D. M., & Selkoe, D. J. (2004) · Protein and Peptide Letters · doi:10.2174/0929866043407174 · Cited by 428 · see citing works

Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders.

Takeda, A., Mallory, M. E., Sundsmo, M. P., Honer, W. G., Hansen, L. A., & Masliah, E. (1998) · Europe PMC (PubMed Central) · Cited by 404 · see citing works

β-Synuclein Inhibits α-Synuclein Aggregation

Hashimoto, M., Rockenstein, E., Mante, M., Mallory, M., & Masliah, E. (2001) · Neuron · doi:10.1016/s0896-6273(01)00462-7 · Cited by 398 · see citing works

Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis

Glabe, C. G., & Kayed, R. (2006) · Neurology · doi:10.1212/01.wnl.0000192103.24796.42 · Cited by 364 · see citing works

Aβ localization in abnormal endosomes: association with earliest Aβ elevations in AD and Down syndrome

Cataldo, A. M., Petanceska, S., Terio, N. B., Peterhoff, C. M., Durham, R., Mercken, M., Mehta, P. D., Buxbaum, J., Haroutunian, V., & Nixon, R. A. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.02.027 · Cited by 363 · see citing works

Alzheimer Disease With Amygdala Lewy Bodies: A Distinct Form of α-Synucleinopathy

Uchikado, H., Lin, W.-L., DeLucia, M. W., & Dickson, D. W. (2006) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000225908.90052.07 · Cited by 359 · see citing works

Annular α-Synuclein Protofibrils Are Produced When Spherical Protofibrils Are Incubated in Solution or Bound to Brain-Derived Membranes

Ding, T. T., Lee, S., Rochet, J., & Lansbury, P. T. (2002) · Biochemistry · doi:10.1021/bi020139h · Cited by 356 · see citing works

NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease

Wakabayashi, K., Matsumoto, K., Takayama, K., Yoshimoto, M., & Takahashi, H. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00891-4 · Cited by 331 · see citing works

In silico study of amyloid β-protein folding and oligomerization

Urbanc, B., Cruz, L., Yun, S., Buldyrev, S. V., Bitan, G., Teplow, D. B., & Stanley, E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408153101 · Cited by 331 · see citing works

The Association of α-Synuclein with Membranes Affects Bilayer Structure, Stability, and Fibril Formation

Zhu, M., Li, J., & Fink, A. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305326200 · Cited by 325 · see citing works

Lipid rafts in health and disease

Michel, V., & Bakovic, M. (2007) · Biology of the Cell · doi:10.1042/bc20060051 · Cited by 306 · see citing works

Accuracy of the Clinical Diagnoses of Lewy Body Disease, Parkinson Disease, and Dementia With Lewy Bodies

Litvan, I., MacIntyre, A. T., Goetz, C. G., Wenning, G. K., Jellinger, K. A., Verny, M., Bartko, J. J., Jankovic, J. J., McKee, A. C., Brandel, J., et al. (1998) · Archives of Neurology · doi:10.1001/archneur.55.7.969 · Cited by 298 · see citing works

Detection of a Novel Intraneuronal Pool of Insoluble Amyloid β Protein that Accumulates with Time in Culture

Skovronsky, D. M., Doms, R. W., & Lee, V. M.-Y. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.4.1031 · Cited by 290 · see citing works

Human recombinant NACP/α-synuclein is aggregated and fibrillated in vitro: Relevance for Lewy body disease

Hashimoto, M., Hsu, L. J., Sisk, A., Xia, Y., Takeda, A., Sundsmo, M. P., & Masliah, E. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00514-9 · Cited by 267 · see citing works

Role of the β‐amyloid protein in Alzheimer's disease

Sisodia, S. S., & Price, D. L. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.5.7896005 · Cited by 262 · see citing works

Zn2+ interaction with Alzheimer amyloid beta protein calcium channels.

Arispe, N. J., Pollard, H. B., & Rojas, E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.4.1710 · Cited by 255 · see citing works

Calpain-Cleavage of α-Synuclein

Dufty, B. M., Warner, L., Hou, S., Jiang, S. X., Gómez‐Isla, T., Leenhouts, K. M., Oxford, J. T., Feany, M. Β., Masliah, E., & Rohn, T. T. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.061232 · Cited by 238 · see citing works

Docking essential dynamics eigenstructures

Mustard, D., & Ritchie, D. W. (2005) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.20569 · Cited by 237 · see citing works

Mixtures of Wild-type and a Pathogenic (E22G) Form of Aβ40 in Vitro Accumulate Protofibrils, Including Amyloid Pores

Lashuel, H. A., Hartley, D. M., Petre, B. M., Wall, J. S., Simon, M. N., Walz, T., & Lansbury, P. T. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00927-6 · Cited by 237 · see citing works

Effect of the overexpression of wild‐type or mutant α‐synuclein on cell susceptibility to insult

Lee, M., Hyun, D., Halliwell, B. B., & Jenner, P. G. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00149.x · Cited by 232 · see citing works

Neuropathology of Alzheimer’s disease: a critical update

Jellinger, K. A., & Bancher, C. (1998) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-7508-8_8 · Cited by 231 · see citing works

Early formation of mature amyloid‐β protein deposits in a mutant APP transgenic model depends on levels of Aβ1–42

Rockenstein, E. M., Mallory, M. E., Mante, M., Sisk, A., & Masliaha, E. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1247 · Cited by 224 · see citing works

Lysosomal system pathways: Genes to neurodegeneration in Alzheimer's disease

Nixon, R. A., & Cataldo, A. M. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9s331 · Cited by 222 · see citing works

Interaction between Aβ Peptide and α Synuclein: Molecular Mechanisms in Overlapping Pathology of Alzheimer’s and Parkinson’s in Dementia with Lewy Body Disease

Mandal, P. K., Pettegrew, J. W., Masliah, E., Hamilton, R. L., & Mandal, R. (2006) · Neurochemical Research · doi:10.1007/s11064-006-9140-9 · Cited by 219 · see citing works

Constant pressure and temperature molecular dynamics simulation of a fully hydrated liquid crystal phase dipalmitoylphosphatidylcholine bilayer

Tu, K., Tobias, D. J., & Klein, M. L. (1995) · Biophysical Journal · doi:10.1016/s0006-3495(95)80126-8 · Cited by 212 · see citing works

Aβ deposition is associated with enhanced cortical α-synuclein lesions in Lewy body diseases

Pletniková, O., West, N. C., Lee, M. K., Rudow, G. L., Skolasky, R. L., Dawson, T. M., Marsh, L., & Troncoso, J. C. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.10.006 · Cited by 209 · see citing works

Are Parkinson’s Disease with dementia and Dementia with lewy Bodies the Same Entity?

Aarsland, D., Ballard, C. G., & Halliday, G. M. (2004) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988704267470 · Cited by 204 · see citing works

NACP, the precursor protein of the non-amyloid beta/A4 protein (A beta) component of Alzheimer disease amyloid, binds A beta and stimulates A beta aggregation.

Yoshimoto, M., Iwai, A., Kang, D. E., Otero, D. A., Xia, Y., & Saitoh, T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9141 · Cited by 202 · see citing works

Oxidative Dimer Formation Is the Critical Rate-Limiting Step for Parkinson's Disease α-Synuclein Fibrillogenesis

Krishnan, S., Chi, E. Y., Wood, S. J., Kendrick, B. S., Li, C., Garzon-Rodriguez, W., Wypych, J., Randolph, T. W., Narhi, L. O., Biere, A. L., et al. (2002) · Biochemistry · doi:10.1021/bi026528t · Cited by 202 · see citing works

A Combinatorial Code for the Interaction of α-Synuclein with Membranes

Kubo, S., Nemani, V. M., Chalkley, R. J., Anthony, M. D., Hattori, N., Mizuno, Y., Edwards, R. H., & Fortin, D. L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504894200 · Cited by 197 · see citing works

The role of α-synuclein in neurodegenerative diseases

Bennett, M. C. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.10.010 · Cited by 195 · see citing works

Interactions Among α-Synuclein, Dopamine, and Biomembranes: Some Clues for Understanding Neurodegeneration in Parkinson's Disease

Rochet, J., Outeiro, T. F., Conway, K. A., Ding, T. T., Volles, M. J., Lashuel, H. A., Bieganski, R. M., Lindquist, S. L., & Lansbury, P. T. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:23:1-2:023 · Cited by 191 · see citing works

Amyloid Accumulation and Pathogensis of Alzheimer’s Disease: Significance of Monomeric, Oligomeric and Fibrillar Aβ

Glabe, C. C. (2006) · Springer eBooks · doi:10.1007/0-387-23226-5_8 · Cited by 187 · see citing works

Stabilization of Partially Folded Conformation during α-Synuclein Oligomerization in Both Purified and Cytosolic Preparations

Uversky, V. N., Lee, H.-J., Li, J., Fink, A. L., & Lee, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100551200 · Cited by 186 · see citing works

The neuropathogenic contributions of lysosomal dysfunction

Bahr, B. A., & Bendiske, J. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01192.x · Cited by 180 · see citing works

Aβ42-Peptide Assembly on Lipid Bilayers

Yip, C. M., Darabie, A. A., & McLaurin, J. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00028-1 · Cited by 177 · see citing works

Membrane Binding and Self-Association of α-Synucleins

Narayanan, V. S., & Scarlata, S. (2001) · Biochemistry · doi:10.1021/bi002952n · Cited by 170 · see citing works

SPECTRUM OF PARKINSON'S DISEASE, PARKINSON'S DEMENTIA, AND LEWY BODY DEMENTIA

McKeith, I. G., & Burn, D. J. (2000) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70230-9 · Cited by 169 · see citing works

Statins reduce neuronal α‐synuclein aggregation in in vitro models of Parkinson’s disease

Bar‐On, P., Crews, L. A., Koob, A. O., Mizuno, H., Adame, A., Spencer, B. J., & Masliah, E. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05254.x · Cited by 166 · see citing works

Dynamics of α‐synuclein aggregation and inhibition of pore‐like oligomer development by β‐synuclein

Tsigelny, I. F., Bar‐On, P., Sharikov, Y., Crews, L. A., Hashimoto, M., Miller, M. A., Keller, S. H., Platoshyn, O., Yuan, J. X. ‐., & Masliah, E. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.05733.x · Cited by 163 · see citing works

Structural Determinants of the Alzheimer's Amyloid β‐Peptide

Soto, C. A., Brañes, M. C., Alvarez, J., & Inestrosa, N. C. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63041191.x · Cited by 153 · see citing works

Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies?

Jellinger, K. A., & Attems, J. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0088-2 · Cited by 153 · see citing works

Binding of Aβ to α- and β-synucleins: identification of segments in α-synuclein/NAC precursor that bind Aβ and NAC

Jensen, P. H., Højrup, P., Hager, H., Nielsen, M. S., JACOBSEN, L., Olesen, O. F., Gliemann, J., & Jakes, R. (1997) · Biochemical Journal · doi:10.1042/bj3230539 · Cited by 143 · see citing works

Axonal Amyloid Precursor Protein Expressed by Neurons in Vitro Is Present in a Membrane Fraction with Caveolae-like Properties

Bouillot, C., Prochiantz, A., Rougon, G. N., & Allinquant, B. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.13.7640 · Cited by 137 · see citing works

Helical α-Synuclein Forms Highly Conductive Ion Channels

Zakharov, L. N., Hulleman, J. D., Dutseva, E. A., Antonenko, Y. N., Rochet, J., & Cramer, W. A. (2007) · Biochemistry · doi:10.1021/bi701275p · Cited by 131 · see citing works

Membrane‐bound β‐amyloid oligomers are recruited into lipid rafts by a fyn‐dependent mechanism

Williamson, R., Usardi, A., Hanger, D. P., & Anderton, B. H. (2007) · The FASEB Journal · doi:10.1096/fj.07-9766com · Cited by 120 · see citing works

Cognitive profiles of individual patients with Parkinson's disease and dementia: Comparison with dementia with lewy bodies and Alzheimer's disease

Janvin, C. C., Larsen, J. P., Salmon, D. P., Galasko, D. R., Hugdahl, K., & Aarsland, D. (2005) · Movement Disorders · doi:10.1002/mds.20726 · Cited by 119 · see citing works

Amyloid β oligomerization is induced by brain lipid rafts

Kim, S., Yi, J.-S., & Ko, Y. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20978 · Cited by 118 · see citing works

Cleavage of α-Synuclein by Calpain: Potential Role in Degradation of Fibrillized and Nitrated Species of α-Synuclein

Mishizen-Eberz, A. J., Norris, E. H., Giasson, B. I., Hodara, R., Ischiropoulos, H., Lee, V. M. ‐., Trojanowski, J. Q., & Lynch, D. R. (2005) · Biochemistry · doi:10.1021/bi047846q · Cited by 117 · see citing works

Alzheimer’s Disease and the Aging Brain

Terry, R. D. (2006) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988706291079 · Cited by 115 · see citing works

Plasma membrane ion permeability induced by mutant α‐synuclein contributes to the degeneration of neural cells

Furukawa, K., Matsuzaki‐Kobayashi, M., Hasegawa, T., Kikuchi, A., Sugeno, N., Itoyama, Y., Wang, Y., Yao, P. J., Bushlin, I., & Takeda, A. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03803.x · Cited by 113 · see citing works

Biochemical Staging of Synucleinopathy and Amyloid Deposition in Dementia With Lewy Bodies

Deramecourt, V., Bombois, S., Maurage, C., Ghestem, A., Drobecq, H., Vanmechelen, E., Lebert, F., Pasquier, F., & Delacourte, A. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000205145.54457.ea · Cited by 109 · see citing works

An antiaggregation gene therapy strategy for Lewy body disease utilizing β-synuclein lentivirus in a transgenic model

Hashimoto, M., Rockenstein, E. M., Mante, M., Crews, L. A., Bar‐On, P., Gage, F. H., Marr, R. A., & Masliah, E. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302349 · Cited by 86 · see citing works

Biological Markers of Alzheimer’s Disease

Klunk, W. E. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00013-x · Cited by 81 · see citing works

ADDLs & protofibrils —the missing links?

Klein, W. L. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00312-8 · Cited by 77 · see citing works

Effects of the cholesterol‐lowering compound methyl‐β‐cyclodextrin in models of α‐synucleinopathy

Bar‐On, P., Rockenstein, E. M., Adame, A., Ho, G. J., Hashimoto, M., & Masliah, E. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04017.x · Cited by 75 · see citing works

Early Stages for Parkinson’s Development: α-Synuclein Misfolding and Aggregation

Yu, J., & Lyubchenko, Y. L. (2008) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-008-9115-5 · Cited by 71 · see citing works

Formation of a High Affinity Lipid-Binding Intermediate during the Early Aggregation Phase of α-Synuclein

Smith, D. P., Tew, D. J., Hill, A. F., Bottomley, S., Masters, C. L., Barnham, K. J., & Cappai, R. (2008) · Biochemistry · doi:10.1021/bi701522m · Cited by 66 · see citing works

Molecular Insights into Alzheimer's Disease

Pettegrew, J. W. (1989) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1989.tb12486.x · Cited by 63 · see citing works

Cortical Lewy body disease and Parkinson's disease dementia

Burn, D. J. (2006) · Current Opinion in Neurology · doi:10.1097/01.wco.0000247607.34697.a2 · Cited by 60 · see citing works

Sequence and structural features of the T-fold, an original tunnelling building unit

Colloc’h, N., Anne Poupon, B., & Mornon, J. (2000) · Proteins Structure Function and Bioinformatics · doi:10.1002/(sici)1097-0134(20000501)39:2 · Cited by 60 · see citing works

Plaque-associated α-synuclein (NACP) pathology in aged transgenic mice expressing amyloid precursor protein

Yang, F., Uéda, K., Chen, P.-P., Ashe, K. H., & Cole, G. M. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02207-6 · Cited by 54 · see citing works

Effects of Cerebrolysin on amyloid-beta deposition in a transgenic model of Alzheimer's disease.

Rockenstein, E. M., Mallory, M. E., Mante, M., Alford, M. F., Windisch, M., Moessler, H., & Masliah, E. (2002) · PubMed · Cited by 48 · see citing works

Dimeric structures of α-synuclein bind preferentially to lipid membranes

Giannakis, E., Pacífico, J., Smith, D. P., Hung, L. W., Masters, C. L., Cappai, R., Wade, J. D., & Barnham, K. J. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.01.012 · Cited by 45 · see citing works

Effects of Cerebrolysin™ on amyloid-β deposition in a transgenic model of Alzheimer’s disease

Rockenstein, E. M., Mallory, M. E., Mante, M., Alford, M. F., Windisch, M., Moessler, H., & Masliah, E. (2002) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6139-5_31 · Cited by 40 · see citing works

Aggregation and fibrillization of prions in lipid membranes.

Kazlauskaite, J., & Pinheiro, T. J. T. (2005) · Biochemical Society Symposia · doi:10.1042/bss0720211 · Cited by 30 · see citing works

α-Synuclein aggregation in pathological aging and Alzheimer's disease: The impact of ß-amyloid plaque level

Lippa, S. M., Lippa, C. F., & Mori, H. (2005) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331750502000506 · Cited by 29 · see citing works

Enhanced accumulation of phosphorylated α‐synuclein in double transgenic mice expressing mutant β‐amyloid precursor protein and presenilin‐1

Kurata, T., Kawarabayashi, T., Murakami, T., Miyazaki, K., Morimoto, N., Ohta, Y., Takehisa, Y., Nagai, M., Ikeda, M., Matsubara, E., et al. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21352 · Cited by 26 · see citing works

MAPAS: a tool for predicting membrane-contacting protein surfaces

Sharikov, Y., Walker, R. C., Greenberg, J. P., Kouznetsova, V. L., Nigám, S. K., Miller, M. A., Masliah, E., & Tsigelny, I. F. (2008) · Nature Methods · doi:10.1038/nmeth0208-119 · Cited by 22 · see citing works

Neuropathological alterations in Alzheimer disease

Serrano-Pozo, A., Frosch, M. P., Masliah, E., & Hyman, B. T. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006189 · Cited by 3,345 · see citing works

The many faces of α-synuclein: from structure and toxicity to therapeutic target

Lashuel, H. A., Overk, C., Oueslati, A., & Masliah, E. (2012) · Nature reviews. Neuroscience · doi:10.1038/nrn3406 · Cited by 1,623 · see citing works

In vivo demonstration that α-synuclein oligomers are toxic

Winner, B., Jappelli, R., Maji, S. K., Desplats, P., Boyer, L. F., Aigner, S., Hetzer, C., Loher, T., Vilar, M., Campioni, S., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100976108 · Cited by 1,487 · see citing works

Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer’s Disease, Parkinson’s Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis

Nguyen, P. H., Ramamoorthy, A., Sahoo, B. R., Zheng, J., Faller, P., Straub, J. E., Domı́nguez, L., Shea, J., Dokholyan, N. V., Simone, A. D., et al. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01122 · Cited by 676 · see citing works

Amyloid oligomers: formation and toxicity of Aβ oligomers

Sakono, M., & Zako, T. (2010) · FEBS Journal · doi:10.1111/j.1742-4658.2010.07568.x · Cited by 602 · see citing works

Basic mechanisms of neurodegeneration: a critical update

Jellinger, K. A. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01010.x · Cited by 608 · see citing works

Synergistic Interactions between Aβ, Tau, and α-Synuclein: Acceleration of Neuropathology and Cognitive Decline

Clinton, L. K., Blurton-Jones, M., Myczek, K., Trojanowski, J. Q., & LaFerla, F. M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0490-10.2010 · Cited by 576 · see citing works

α-Synuclein misfolding and aggregation: Implications in Parkinson’s disease pathogenesis

Mehra, S., Sahay, S., & Maji, S. K. (2019) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2019.03.001 · Cited by 507 · see citing works

Development of a Biochemical Diagnosis of Parkinson Disease by Detection of α-Synuclein Misfolded Aggregates in Cerebrospinal Fluid

Shahnawaz, M., Tokuda, T., Waragai, M., Méndez, N., Ishii, R., Trenkwalder, C., Mollenhauer, B., & Soto, C. A. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.4547 · Cited by 485 · see citing works

Recent Advances in the Genetics of Parkinson's Disease

Martin, I., Dawson, V. L., & Dawson, T. M. (2011) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-082410-101440 · Cited by 438 · see citing works

Interactions of pathological proteins in neurodegenerative diseases

Spires‐Jones, T. L., Attems, J., & Thal, D. R. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1709-7 · Cited by 424 · see citing works

Exosomes: Vehicles for the Transfer of Toxic Proteins Associated with Neurodegenerative Diseases?

Bellingham, S. A., Guo, B. B., Coleman, B. M., & Hill, A. F. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00124 · Cited by 355 · see citing works

α-synuclein in the pathophysiology of Alzheimer’s disease

Twohig, D., & Nielsen, H. M. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0320-x · Cited by 374 · see citing works

Review on Alzheimer’s Disease: Inhibition of Amyloid Beta and Tau Tangle Formation

Ashrafian, H., Zadeh, E. H., & Khan, R. H. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.11.192 · Cited by 368 · see citing works

Calcium signaling in neurodegeneration

Marambaud, P., Dreses‐Werringloer, U., & Vingtdeux, V. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-20 · Cited by 352 · see citing works

Oligomeric Intermediates in Amyloid Formation: Structure Determination and Mechanisms of Toxicity

Fändrich, M. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2012.01.006 · Cited by 339 · see citing works

Cell-to-cell transmission of non-prion protein aggregates

Lee, S., Desplats, P., Sigurdson, C. J., Tsigelny, I. F., & Masliah, E. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.145 · Cited by 307 · see citing works

Amyloid β, Tau, and α-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseases

Sengupta, U., & Kayed, R. (2022) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2022.102270 · Cited by 303 · see citing works

The vermiform appendix impacts the risk of developing Parkinson’s disease

Killinger, B. A., Madaj, Z., Sikora, J. W., Rey, N. L., Haas, A. J., Vepa, Y., Lindqvist, D., Chen, H., Thomas, P. M., Brundin, P., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aar5280 · Cited by 274 · see citing works

Protein Misfolded Oligomers: Experimental Approaches, Mechanism of Formation, and Structure-Toxicity Relationships

Bemporad, F., & Chiti, F. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.02.003 · Cited by 275 · see citing works

First‐in‐human assessment of PRX002, an anti–α‐synuclein monoclonal antibody, in healthy volunteers

Schenk, D. B., Koller, M., NESS, D. K., Griffith, S. G., Grundman, M., Zago, W. M., Soto, J., Atiee, G. J., Ostrowitzki, S., & Kinney, G. G. (2016) · Movement Disorders · doi:10.1002/mds.26878 · Cited by 248 · see citing works

Amyloid-Beta (Aβ) Plaques Promote Seeding and Spreading of Alpha-Synuclein and Tau in a Mouse Model of Lewy Body Disorders with Aβ Pathology

Bassil, F., Brown, H. J., Pattabhiraman, S., Iwasyk, J. E., Maghames, C. M., Meymand, E. S., Cox, T. O., Riddle, D. M., Zhang, B., Trojanowski, J. Q., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.10.010 · Cited by 243 · see citing works

Global quantitative analysis of the human brain proteome in Alzheimer’s and Parkinson’s Disease

Ping, L., Duong, D. M., Yin, L., Gearing, M., Lah, J. J., Levey, A. I., & Seyfried, N. T. (2018) · Scientific Data · doi:10.1038/sdata.2018.36 · Cited by 221 · see citing works

Cross-Seeding of Misfolded Proteins: Implications for Etiology and Pathogenesis of Protein Misfolding Diseases

Morales, R., Moreno‐González, I., & Soto, C. A. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003537 · Cited by 220 · see citing works

Cross‐seeding effects of amyloid β‐protein and α‐synuclein

Ono, K., Takahashi, R., Ikeda, T., & Yamada, M. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07847.x · Cited by 213 · see citing works

Molecular interaction between type 2 diabetes and Alzheimer’s disease through cross-seeding of protein misfolding

Moreno‐González, I., Edwards, G. A., Salvadores, N., Shahnawaz, M., Díaz‐Espinoza, R., & Soto, C. A. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.230 · Cited by 210 · see citing works

Increased Accumulation of Intraneuronal Amyloid β in HIV-Infected Patients

HNRC, Achim, C. L., Adame, A., Dumaop, W., Everall, I. P., & Masliah, E. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9152-8 · Cited by 205 · see citing works

Neuropathology of dementia in patients with Parkinson’s disease: a systematic review of autopsy studies

Smith, C., Malek, N., Grosset, K. A., Cullen, B., Gentleman, S., & Grosset, D. G. (2019) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2019-321111 · Cited by 202 · see citing works

Cerebrospinal fluid α-synuclein in neurodegenerative disorders—A marker of synapse loss?

Öhrfelt, A., Grognet, P., Andreasen, N., Wallin, A., Vanmechelen, E., Blennow, K., & Zetterberg, H. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.11.015 · Cited by 198 · see citing works

α-Synuclein Alters Toll-Like Receptor Expression

Béraud, D., Twomey, M. A., Bloom, B., Mittereder, A., Ton, V., Neitzke, K., Chasovskikh, S., Mhyre, T. R., & Maguire‐Zeiss, K. A. (2011) · Frontiers in Neuroscience · doi:10.3389/fnins.2011.00080 · Cited by 199 · see citing works

Targeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer’s disease immunotherapeutics

Goure, W. F., Krafft, G. A., Jerecic, J., & Hefti, F. (2014) · Alzheimer's Research &amp; Therapy · doi:10.1186/alzrt272 · Cited by 190 · see citing works

Confluence of α-Synuclein, Tau, and β-Amyloid Pathologies in Dementia With Lewy Bodies

Colom‐Cadena, M., Gelpí, E., Charif, S., Belbin, O., Blesa, R., Martı́, M. J., Clarimón, J., & Lleó, A. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000018 · Cited by 189 · see citing works

Efficient RT-QuIC seeding activity for α-synuclein in olfactory mucosa samples of patients with Parkinson’s disease and multiple system atrophy

Luca, C. M. G. D., Elia, A. E., Portaleone, S. M., Cazzaniga, F. A., Rossi, M., Bistaffa, E., Cecco, E. D., Narkiewicz, J., Salzano, G., Carletta, O., et al. (2019) · Translational Neurodegeneration · doi:10.1186/s40035-019-0164-x · Cited by 186 · see citing works

Simulation Studies of Amyloidogenic Polypeptides and Their Aggregates

Ilie, I. M., & Caflisch, A. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00731 · Cited by 177 · see citing works

Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease

Parnetti, L., Farotti, L., Eusebi, P., Chiasserini, D., Carlo, C. D., Giannandrea, D., Salvadori, N., Lisetti, V., Tambasco, N., Rossi, A., et al. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00053 · Cited by 177 · see citing works

Role of α‐synuclein penetration into the membrane in the mechanisms of oligomer pore formation

Tsigelny, I. F., Sharikov, Y., Wrasidlo, W., Gonzalez, T., Desplats, P., Crews, L. A., Spencer, B. J., & Masliah, E. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08489.x · Cited by 170 · see citing works

Cerebrospinal fluid Tau/α‐synuclein ratio in Parkinson's disease and degenerative dementias

Parnetti, L., Chiasserini, D., Bellomo, G., Giannandrea, D., Carlo, C. D., Qureshi, M. M., Ardah, M. T., Varghese, S., Bonanni, L., Borroni, B., et al. (2011) · Movement Disorders · doi:10.1002/mds.23670 · Cited by 170 · see citing works

PLGA nanoparticles modified with a BBB-penetrating peptide co-delivering Aβ generation inhibitor and curcumin attenuate memory deficits and neuropathology in Alzheimer's disease mice

Huang, N., Lü, S., Liu, X., Zhu, J., Wang, Y., & Liu, R. (2017) · Oncotarget · doi:10.18632/oncotarget.20944 · Cited by 170 · see citing works

Cross-talk between amyloidogenic proteins in type-2 diabetes and Parkinson’s disease

Horváth, I., & Wittung-Stafshede, P. E. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1610371113 · Cited by 161 · see citing works

Interactions of Pathological Hallmark Proteins

Oláh, J., Vincze, O., Virok, D. P., Simon, D., Bozsó, Z., Tőkési, N., Horváth, I., Hlavanda, E., Kovács, J., Magyar, A., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.243907 · Cited by 156 · see citing works

Metabolic Activity Determines Efficacy of Macroautophagic Clearance of Pathological Oligomeric α-Synuclein

Yu, W. H., Dorado, B., Figueroa, H. Y., Wang, L., Planel, E., Cookson, M. R., Clark, L. N., & Duff, K. E. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080928 · Cited by 155 · see citing works

Biophysical processes underlying cross-seeding in amyloid aggregation and implications in amyloid pathology

Ivanova, M. I., Lin, Y., Lee, Y., Zheng, J., & Ramamoorthy, A. (2020) · Biophysical Chemistry · doi:10.1016/j.bpc.2020.106507 · Cited by 153 · see citing works

Cross-interactions between the Alzheimer Disease Amyloid-β Peptide and Other Amyloid Proteins: A Further Aspect of the Amyloid Cascade Hypothesis

Luo, J., Wärmländer, S. K. T. S., Gräslund, A., & Abrahams, J. P. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.r116.714576 · Cited by 142 · see citing works

Structural characteristics of thermostable immunogenic outer membrane protein from Salmonella enterica serovar Typhi

Rabbani, G., Kaur, J., Ahmad, E., Khan, R. H., & Jain, S. K. (2013) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-013-5123-3 · Cited by 142 · see citing works

Exploratory analysis of neuropsychological and neuroanatomical correlates of progressive mild cognitive impairment in Parkinson's disease

Lee, J. E., Cho, K. H., Song, S. K., Kim, H. J., Lee, H. S., Sohn, Y. H., & Lee, P. H. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-305062 · Cited by 144 · see citing works

Examining the mechanisms that link β-amyloid and α-synuclein pathologies

Marsh, S. E., & Blurton-Jones, M. M. (2012) · Alzheimer s Research & Therapy · doi:10.1186/alzrt109 · Cited by 137 · see citing works

Fundamentals of cross-seeding of amyloid proteins: an introduction

Ren, B., Zhang, Y., Zhang, M., Liu, Y., Zhang, D., Gong, X., Feng, Z., Tang, J., Chang, Y., & Zheng, J. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb01871a · Cited by 135 · see citing works

Immunotherapeutic Approaches Targeting Amyloid-β, α-Synuclein, and Tau for the Treatment of Neurodegenerative Disorders

Valera, E., Spencer, B. J., & Masliah, E. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0397-z · Cited by 129 · see citing works

α-Synuclein and Neuronal Cell Death

Yasuda, T., Nakata, Y., & Mochizuki, H. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8327-0 · Cited by 130 · see citing works

Interaction between pathogenic proteins in neurodegenerative disorders

Jellinger, K. A. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01507.x · Cited by 128 · see citing works

P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer’s disease

Farmer, K. M., Ghag, G., Puangmalai, N., Montalbano, M., Bhatt, N. N., & Kayed, R. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01012-6 · Cited by 126 · see citing works

Inclusion-body myositis: muscle-fiber molecular pathology and possible pathogenic significance of its similarity to Alzheimer’s and Parkinson’s disease brains

Askanas, V., & Engel, W. K. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0449-0 · Cited by 122 · see citing works

Structural Characteristics of α-Synuclein Oligomers

Cremades, N., Chen, S. W., & Dobson, C. M. (2016) · International review of cytology · doi:10.1016/bs.ircmb.2016.08.010 · Cited by 118 · see citing works

Inhibition of amyloid-β plaque formation by α-synuclein

Bachhuber, T., Katzmarski, N., McCarter, J. F., Loreth, D., Tahirović, S., Kamp, F., Abou‐Ajram, C., Nuscher, B., Serrano‐Pozo, A., Müller, A., et al. (2015) · Nature Medicine · doi:10.1038/nm.3885 · Cited by 116 · see citing works

A comparative analysis of cognitive profiles and white-matter alterations using voxel-based diffusion tensor imaging between patients with Parkinson's disease dementia and dementia with Lewy bodies

Lee, J., Park, H., Park, B., Song, S. K., Sohn, Y. H., Lee, J. D., & Lee, P. H. (2009) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.184747 · Cited by 114 · see citing works

α-Synuclein modulates tau spreading in mouse brains

Bassil, F., Meymand, E. S., Brown, H. J., Xu, H. W., Cox, T. O., Pattabhiraman, S., Maghames, C. M., Wu, Q., Zhang, B., Trojanowski, J. Q., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20192193 · Cited by 111 · see citing works

Structural and Functional Insights into α-Synuclein Fibril Polymorphism

Mehra, S., Gadhe, L. G., Bera, R., Sawner, A. S., & Maji, S. K. (2021) · Biomolecules · doi:10.3390/biom11101419 · Cited by 109 · see citing works

The prion-like spreading of α-synuclein: From in vitro to in vivo models of Parkinson’s disease

Vargas, J., Grudina, C., & Zurzolo, C. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.01.012 · Cited by 106 · see citing works

Protein aggregation as a paradigm of aging

Lindner, A. B., & Démarez, A. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.06.005 · Cited by 106 · see citing works

CSF α-synuclein improves diagnostic and prognostic performance of CSF tau and Aβ in Alzheimer’s disease

Toledo, J. B., Korff, A., Shaw, L. M. J., Trojanowski, J. Q., & Zhang, J. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1148-z · Cited by 106 · see citing works

Phenolic compounds prevent the oligomerization of α‐synuclein and reduce synaptic toxicity

Takahashi, R., Ono, K., Takamura, Y., Mizuguchi, M., Ikeda, T., Nishijo, H., & Yamada, M. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13180 · Cited by 103 · see citing works

Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities

Visanji, N. P., Lang, A. E., & Kovács, G. G. (2019) · Translational Neurodegeneration · doi:10.1186/s40035-019-0172-x · Cited by 99 · see citing works

Alpha-synuclein: a pathological factor with Aβ and tau and biomarker in Alzheimer’s disease

Shim, K. H., Kang, M. J., Youn, Y. C., An, S. S. A., & Kim, S. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-01150-0 · Cited by 98 · see citing works

Cortical Lewy bodies and Aβ burden are associated with prevalence and timing of dementia in Lewy body diseases

Ruffmann, C., Calboli, F. C. F., Bravi, I., Gveric, D. O., Curry, L. K., de Smith, A. J., Pavlou, S., Buxton, J. L., Blakemore, A. I. F., Takousis, P., et al. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12294 · Cited by 96 · see citing works

α-Synuclein in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment

Korff, A., Liu, C., Ginghina, C., Shi, M., Zhang, J., & Initiative, F. T. A. D. N. (2013) · Journal of Alzheimer’s Disease · doi:10.3233/jad-130458 · Cited by 95 · see citing works

Methylation Status and Neurodegenerative Markers in Parkinson Disease

Obeid, R., Schadt, A. A., Dillmann, U., Kostopoulos, P., Fassbender, K. C., & Herrmann, W. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2009.125021 · Cited by 95 · see citing works

Functional and Pathological Effects of α-Synuclein on Synaptic SNARE Complexes

Gao, V., Briano, J. A., Komer, L. E., & Burré, J. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167714 · Cited by 96 · see citing works

Immunotherapies for Aging-Related Neurodegenerative Diseases—Emerging Perspectives and New Targets

Kwon, S., Iba, M., Kim, C., & Masliah, E. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00853-2 · Cited by 92 · see citing works

Interaction between NH2-tau fragment and Aβ in Alzheimer's disease mitochondria contributes to the synaptic deterioration

Amadoro, G., Corsetti, V., Atlante, A., Florenzano, F., Capsoni, S., Bussani, R., Mercanti, D., & Calissano, P. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.08.001 · Cited by 94 · see citing works

Cerebrospinal fluid biomarkers in parkinsonian conditions: an update and future directions

Magdalinou, N. K., Lees, A. J., & Zetterberg, H. (2014) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-307539 · Cited by 93 · see citing works

A cross‐sectional study of α‐synuclein seed amplification assay in Alzheimer's disease neuroimaging initiative: Prevalence and associations with Alzheimer's disease biomarkers and cognitive function

Tosun, D., Hausle, Z., Iwaki, H., Thropp, P., Lamoureux, J., Lee, E. B., MacLeod, K., McEvoy, S., Nalls, M. A., Perrin, R. J., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13858 · Cited by 86 · see citing works

Role of Synucleins in Alzheimer’s Disease

Crews, L. A., Tsigelny, I. F., Hashimoto, M., & Masliah, E. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9073-6 · Cited by 84 · see citing works

Effect of melatonin on α-synuclein self-assembly and cytotoxicity

Ono, K., Mochizuki, H., Ikeda, T., Nihira, T., Takasaki, J., Teplow, D. B., & Yamada, M. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.10.015 · Cited by 84 · see citing works

Extracellular α‐synuclein alters synaptic transmission in brain neurons by perforating the neuronal plasma membrane

Pacheco, C. R., Morales, C. N., Muñoz, A. R., Muñoz, F. J., Gallegos, S., Caviedes, P. A., Aguayo, L. G., & Opazo, C. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13060 · Cited by 83 · see citing works

Amylin–Aβ oligomers at atomic resolution using molecular dynamics simulations: a link between Type 2 diabetes and Alzheimer's disease

Baram, M., Atsmon‐Raz, Y., Ma, B., Nussinov, R., & Miller, Y. (2015) · Physical Chemistry Chemical Physics · doi:10.1039/c5cp03338a · Cited by 82 · see citing works

γ-Synuclein: Seeding of α-Synuclein Aggregation and Transmission between Cells

Surgucheva, I. G., Sharov, V. S., & Surguchov, A. P. (2012) · Biochemistry · doi:10.1021/bi300478w · Cited by 81 · see citing works

Amyloid-Beta Peptides Trigger Aggregation of Alpha-Synuclein In Vitro

Köppen, J., Schulze, A., Machner, L., Wermann, M., Eichentopf, R., Guthardt, M., Hähnel, A., Klehm, J., Kriegeskorte, M.-C., Hartlage‐Rübsamen, M., et al. (2020) · Molecules · doi:10.3390/molecules25030580 · Cited by 78 · see citing works

Regional Overlap of Pathologies in Lewy Body Disorders

Colom‐Cadena, M., Grau‐Rivera, O., Planellás, L., Cerquera‐Cleves, C., Morenas‐Rodríguez, E., Helgueta, S., Muñoz, L., Kulisevsky, J., Martı́, M. J., Tolosa, E. S., et al. (2017) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlx002 · Cited by 79 · see citing works

Cross Currents in Protein Misfolding Disorders: Interactions and Therapy

Morales, R., Green, K., & Soto, C. (2009) · CNS &amp; Neurological Disorders - Drug Targets · doi:10.2174/187152709789541998 · Cited by 72 · see citing works

Oligomeric α‐synuclein and β‐amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases

Williams, S. M., Schulz, P., & Sierks, M. R. (2015) · European Journal of Neuroscience · doi:10.1111/ejn.13056 · Cited by 71 · see citing works

The contribution of biophysical and structural studies of protein self-assembly to the design of therapeutic strategies for amyloid diseases

Cremades, N., & Dobson, C. M. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.07.009 · Cited by 70 · see citing works

α‐Synuclein mediates alterations in membrane conductance: a potential role for α‐synuclein oligomers in cell vulnerability

Feng, L., Federoff, H. J., Vicini, S., & Maguire‐Zeiss, K. A. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07266.x · Cited by 70 · see citing works

The Neuronal Tau Protein Blocks in Vitro Fibrillation of the Amyloid-β (Aβ) Peptide at the Oligomeric Stage

Wallin, C., Hiruma, Y., Wärmländer, S. K. T. S., Huvent, I., Jarvet, J., Abrahams, J. P., Gräslund, A., Lippens, G. M., & Luo, J. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.7b13623 · Cited by 67 · see citing works

Amyloid-β oligomers as a template for secondary amyloidosis in Alzheimer's disease

Guerrero‐Munoz, M. J., Castillo‐Carranza, D. L., Krishnamurthy, S., Paulucci-Holthauzen, A. A., Sengupta, U., Lasagna‐Reeves, C. A., Ahmad, Y., Jackson, G. R., & Kayed, R. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.08.008 · Cited by 67 · see citing works

Amyloid β-interacting partners in Alzheimer's disease: From accomplices to possible therapeutic targets

Han, S.-H., Park, J.-C., & Mook-Jung, I. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.12.004 · Cited by 67 · see citing works

Striatal and C ortical β‐ A myloidopathy and C ognition in P arkinson's D isease

Shah, N., Frey, K. A., Müller, M. L. T. M., Petrou, M., Kotagal, V., Koeppe, R. A., Scott, P. J. H., Albin, R. L., & Bohnen, N. I. (2015) · Movement Disorders · doi:10.1002/mds.26369 · Cited by 63 · see citing works

Prion-like features of misfolded Aβ and tau aggregates

Morales, R., Callegari, K., & Soto, C. A. (2015) · Virus Research · doi:10.1016/j.virusres.2014.12.031 · Cited by 65 · see citing works

Autophagy in Dementias

Kragh, C. L., Ubhi, K. K., Wyss‐Coray, T., & Masliah, E. (2011) · Brain Pathology · doi:10.1111/j.1750-3639.2011.00545.x · Cited by 66 · see citing works

Interaction between -Synuclein and Other Proteins in Neurodegenerative Disorders

Jellinger, K. A. (2011) · The Scientific World JOURNAL · doi:10.1100/2011/371893 · Cited by 63 · see citing works

Insights into the Molecular Mechanisms of Alzheimer’s and Parkinson’s Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology

Coskuner‐Weber, O., & Uversky, V. N. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020336 · Cited by 66 · see citing works

Potential biomarkers and novel pharmacological targets in protein aggregation-related neurodegenerative diseases

Giacomelli, C., Daniele, S., & Martini, C. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.01.017 · Cited by 64 · see citing works

Somatostatin in Alzheimer's disease: A new Role for an Old Player

Solarski, M., Wang, H., Wille, H., & Schmitt‐Ulms, G. (2017) · Prion · doi:10.1080/19336896.2017.1405207 · Cited by 62 · see citing works

Selective lowering of synapsins induced by oligomeric α-synuclein exacerbates memory deficits

Larson, M. E., Greimel, S. J., Amar, F., LaCroix, M., Boyle, G., Sherman, M. A., Schley, H., Miel, C., Schneider, J. A., Kayed, R., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1704698114 · Cited by 61 · see citing works

Soluble endogenous oligomeric α-synuclein species in neurodegenerative diseases: Expression, spreading, and cross-talk

Kayed, R., Dettmer, U., & Lesné, S. (2020) · Journal of Parkinson s Disease · doi:10.3233/jpd-201965 · Cited by 62 · see citing works

Cell-to-Cell Transmission of α-Synuclein Aggregates

Lee, S., Desplats, P., Lee, H.-J., Spencer, B. J., & Masliah, E. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-551-0_23 · Cited by 60 · see citing works

Interaction between Aβ Peptide and α Synuclein: Molecular Mechanisms in Overlapping Pathology of Alzheimer’s and Parkinson’s in Dementia with Lewy Body Disease

Mandal, P. K., Pettegrew, J. W., Masliah, E., Hamilton, R. L., & Mandal, R. (2006) · Neurochemical Research · doi:10.1007/s11064-006-9140-9 · Cited by 219 · see citing works

Oligomerization by co-assembly of β-amyloid and α-synuclein

Kim, J. R. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1153839 · Cited by 13 · see citing works

Role of Synucleins in Alzheimer’s Disease

Crews, L. A., Tsigelny, I. F., Hashimoto, M., & Masliah, E. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9073-6 · Cited by 84 · see citing works

Examining the mechanisms that link beta-amyloid and alpha-synuclein pathologies

Marsh, S., & Blurton-Jones, M. (2012) · UCL Discovery (University College London)

Non-Amyloid-β Component of Human α-Synuclein Oligomers Induces Formation of New Aβ Oligomers: Insight into the Mechanisms That Link Parkinson’s and Alzheimer’s Diseases

Atsmon‐Raz, Y., & Miller, Y. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00204 · Cited by 53 · see citing works